Novel targeted drug shows promise in advanced basal cell carcinoma

    loading  Checking for direct PDF access through Ovid

Abstract

▪ A small molecule inhibitor of the Hedgehog signalling pathway appeared safe and effective in patients with advanced basal cell cancer in a Phase I trial, researchers reported at the Meeting.

Related Topics

    loading  Loading Related Articles